P3
Illumina Inc.
Application Filed: 2020-03-10
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88829158 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Susan M. Natland |
| Attorney Docket Number | ILLINCT.679T |
Timeline
| 2020-03-10 | Application Filed |
| 2020-03-13 | Location: NEW APPLICATION PROCESSING |
| 2020-03-13 | Status: Live/Pending |
| 2020-03-13 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Illumina Inc. |
| Address | 5200 Illumina Way San Diego DE 92122 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0011 | Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits containing reagents and a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzyme substrates, buffers, chemical preparations, or biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes |
| GS0051 | Biological diagnostics and genetic testing agents, assays, and buffers for medical and veterinary use; reagents, enzymes, and nucleotides for medical and veterinary use; chemical preparations and biological preparations for use in diagnostics, genetic testing, infectious disease treatment, cancer treatment and neo-natal treatment for medical and veterinary use; diagnostic reagents and preparations for medical and veterinary use; kits comprised primarily of reagents and comprised secondarily of a protocol in the form of printed instructions for use thereof for medical purposes; kits comprised of nucleotides, reagents, enzyme substrates, buffers, chemical preparations, biological preparations for medical genetic testing and medical diagnostic purposes; biological diagnostics and genetic testing agents, assays, and buffers for medical and veterinary use in the fields of medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, genetic testing, and genetics; reagents, enzymes, and nucleotides for medical and veterinary use in the fields of medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, genetic testing, and genetics; chemical preparations and biological preparations for use in diagnostics, genetic testing, infectious disease treatment, cancer treatment and neo-natal treatment for medical and veterinary use in the fields of medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, genetic testing, and genetics |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-03-13 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-03-17 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-05-29 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-06-02 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-06-02 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-06-02 | 6 GNRN O:Outgoing Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2020-06-25 | 7 PARI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2020-07-08 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-07-08 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-07-08 | 10 TEME I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-12-10 | 11 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2020-12-16 | 12 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2020-12-16 | 13 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2020-12-16 | 14 GNS3 O:Outgoing Correspondence |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2021-08-27 | 15 RCCK S: |
| EXAMINERS AMENDMENT -WRITTEN | 2021-09-24 | 16 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-09-24 | 17 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-09-24 | 18 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-09-24 | 19 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-09-24 | 20 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-10-13 | 21 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-11-02 | 22 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-11-02 | 23 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-12-28 | 24 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-06-07 | 25 EEXT I:Incoming Correspondence |
| TEAS STATEMENT OF USE RECEIVED | 2022-06-09 | 26 EISU I:Incoming Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2022-06-09 | 27 ERTD I:Incoming Correspondence |
| DIVISIONAL REQUEST RECEIVED | 2022-06-09 | 28 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2022-06-28 | 29 DPCC D:Assigned to Examiner |
| SOU EXTENSION 1 FILED | 2022-06-07 | 30 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2022-06-28 | 31 EX1G S: |
| CORRECTED NOA E-MAILED | 2022-06-29 | 32 NOAC E:E-Mail |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-06-29 | 33 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-12-15 | 34 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2022-12-15 | 35 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2022-12-15 | 36 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-12-17 | 37 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2023-05-17 | 38 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2023-05-17 | 39 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2023-05-17 | 40 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-05-19 | 41 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2023-12-04 | 42 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2023-12-04 | 43 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2023-12-06 | 44 SUPC I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2023-12-09 | 45 DOCK D:Assigned to Examiner |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2023-12-10 | 46 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2023-12-12 | 47 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2024-01-16 | 48 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-01-16 | 49 NRCC E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 